GlassScriptPhysician profile
Amy B Mashburn
NPI 1487652533
$2,131.30
in general payments reported to CMS, 2019-2025
17 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.00 · 2020: $372 · 2021: $436 · 2022: $770 · 2024: $347 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $691.35 | 2020-2024 | Airsupra |
| Glaxosmithkline, LLC. | $278.67 | 2020-2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $255.12 | 2020-2022 | |
| Genentech USA, INC. | $190.57 | 2022-2024 | Xolair |
| Ars Pharmaceuticals Operations, INC. | $134.38 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $103.51 | 2020-2022 | |
| Novo Nordisk INC | $73.00 | 2019 | |
| Genzyme Corporation | $69.92 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $61.54 | 2020 | |
| Kaleo, INC. | $52.40 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.39 | 2020-2021 | |
| Adma Biomanufacturing LLC | $40.04 | 2022 | |
| Pfizer INC. | $38.39 | 2020 | |
| Alk-Abello, INC | $32.57 | 2020-2021 | |
| Biocryst US Sales Co., LLC | $27.72 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $17.74 | 2022 | |
| Csl Behring | $16.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mashburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.